ArticleJournal of nanobiotechnology2024

ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway.

Yixuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.